Literature DB >> 19147247

Assessment of rectal distention in radiotherapy of prostate cancer using daily megavoltage CT image guidance.

Benedikt Engels1, Koen Tournel, Guy Soete, Guy Storme.   

Abstract

PURPOSE: Assessment of rectal distention in a group of patients who are not receiving daily rectum emptying procedures during a course of prostate cancer radiotherapy to investigate which patients could benefit from daily rectum emptying. METHODS AND MATERIALS: Eighteen patients underwent daily megavoltage CT (MVCT) scanning with positioning based on bony anatomy. Emptying the rectum was only performed before planning CT and not during the actual treatment. The rectal average cross-sectional area (CSA) was determined on the MVCTs. The relative CSA (CSA(rel)) was defined as CSA on MVCT / CSA on planning CT. Additional prostate soft tissue matching was performed to verify the influence of rectal distention on prostate motion.
RESULTS: Two distinct subgroups could be defined a posteriori. One group had a limited and stable rectal distention with a CSA (mean+/-SD) of 6.6+/-2.1cm(2), in contrast with a second group with large and variable rectal filling with a CSA of 9.5+/-3.7cm(2) (p<0.01). Mean anterior-posterior prostate displacement was 0.4+/-2.4 mm in the stable group versus -2.4+/-6.1 mm in the unstable group (p<0.01). A mean CSA(rel) of 1.35 of the first 3 days as cut-off value allowed for a correct a priori classification of 90% and 85% of the patients from groups 1 and 2, respectively.
CONCLUSION: Based on a few measurements of the CSA by daily MVCT imaging at the first days of treatment, rectum emptying may be omitted in part of the patients.

Entities:  

Mesh:

Year:  2009        PMID: 19147247     DOI: 10.1016/j.radonc.2008.12.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Which bowel preparation is best? Comparison of a high-fibre diet leaflet, daily microenema and no preparation in prostate cancer patients treated with radical radiotherapy to assess the effect on planned target volume shifts due to rectal distension.

Authors:  S Yahya; A Zarkar; E Southgate; P Nightingale; G Webster
Journal:  Br J Radiol       Date:  2013-08-30       Impact factor: 3.039

2.  Learning image context for segmentation of the prostate in CT-guided radiotherapy.

Authors:  Wei Li; Shu Liao; Qianjin Feng; Wufan Chen; Dinggang Shen
Journal:  Phys Med Biol       Date:  2012-02-17       Impact factor: 3.609

3.  Image-guided radiotherapy of the prostate using daily CBCT: the feasibility and likely benefit of implementing a margin reduction.

Authors:  I F Maund; R J Benson; J Fairfoul; J Cook; R Huddart; A Poynter
Journal:  Br J Radiol       Date:  2014-10-29       Impact factor: 3.039

4.  Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy.

Authors:  Maria Thor; Aditya Apte; Joseph O Deasy; Ludvig Paul Muren
Journal:  Acta Oncol       Date:  2012-12-04       Impact factor: 4.089

5.  Evaluation of image-guidance strategies for prostate cancer.

Authors:  T Piotrowski; K Kaczmarek; T Bajon; A Ryczkowski; A Jodda; J Kaźmierska
Journal:  Technol Cancer Res Treat       Date:  2013-08-31

Review 6.  Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment.

Authors:  J E Scaife; G C Barnett; D J Noble; R Jena; S J Thomas; C M L West; N G Burnet
Journal:  Br J Radiol       Date:  2015-05-26       Impact factor: 3.039

7.  Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion.

Authors:  J Scaife; K Harrison; M Romanchikova; A Parker; M Sutcliffe; S Bond; S Thomas; S Freeman; R Jena; A Bates; N Burnet
Journal:  Br J Radiol       Date:  2014-08-20       Impact factor: 3.039

8.  Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer.

Authors:  Jessica E Scaife; Simon J Thomas; Karl Harrison; Marina Romanchikova; Michael P F Sutcliffe; Julia R Forman; Amy M Bates; Raj Jena; M Andrew Parker; Neil G Burnet
Journal:  Br J Radiol       Date:  2015-07-24       Impact factor: 3.039

9.  The usefulness of fleet rectal enemas on high-dose-rate intracavitary cervical cancer brachytherapy. A prospective trial.

Authors:  Ignacio Andres; Manuel Gutierrez-Perez; Maria Pilar Rodriguez-Vela; Roberto Berenguer; Marimar Sevillano; Manuel Aguayo; Meritxell Arenas; Angeles Rovirosa; Yashmina Murria-Perez; Sebastia Sabater
Journal:  J Contemp Brachytherapy       Date:  2017-05-30

10.  Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer.

Authors:  Hanne Tøndel; Arne Solberg; Stian Lydersen; Christer Andre Jensen; Stein Kaasa; Jo-Åsmund Lund
Journal:  Clin Transl Radiat Oncol       Date:  2019-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.